Clinical Trial Update: A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants [Phase 1]

View source ↗

Summary

This Phase I trial evaluates AHB-171 in healthy participants and patients with chronic hepatitis B; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• AHB-171 (AHB-171)

Snippet

Sponsor: Ausper Biopharma Co., Ltd. | Conditions: Chronic Hepatitis B Infection | Phase 1 | Status: NOT_YET_RECRUITING